Onconova Therapeutics, Inc. 4
4 · Onconova Therapeutics, Inc. · Filed Jun 30, 2016
Insider Transaction Report
Form 4
Maniar Manoj
SVP - Product Development
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2016-06-30−50→ 10,342 totalExercise: $6.50From: 2016-01-26Exp: 2026-01-26→ Common Stock (50 underlying) - Exercise/Conversion
Common Stock
2016-06-30$6.50/sh+50$325→ 50 total